FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Find answers to all your questions on live LALPATHLAB message board: Is LALPATHLAB buy or sell? Should I buy LALPATHLAB shares? Why are LALPATHLAB shares falling? Should I invest in LALPATHLAB stock?

forum

LALPATHLAB Share Price Discussion

Dr. Lal Path Labs Ltd.
NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Sector: Pharmaceuticals and health care
Reputation: 2,343 • Mar 4 6:51 AM

LALPATHLAB


Type
Buy
Instrument
LALPATHLAB
Entry Price
₹1,708
Price@Trade
₹1,709.85
Target Price
₹1,750
Stop Price
₹1,680
Valid Till
Apr 3, 2020 3:20 AM
Margin
₹1,708 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹1,680
Net P&L
-₹28.01 (-1.64%)
Like
Reply (2)
NSE:LALPATHLAB price when posted: 1,709.85
2 Replies
TrackerBot @trackerbot
Mar 4 6:52 AM

Update
Trade Entered
Entry Price
₹1,708
TrackerBot @trackerbot
Mar 4 7:14 AM

Update
Stoploss Hit
Exit Price
₹1,680
Recent posts in LALPATHLAB
Reputation: 11,331 • May 19 5:00 AM

Prabhudas Lilladher target on LALPATHLAB
Date: 19-May-20 Broker: Prabhudas Lilladher Price @ Call: 1583.35 Target: 895 Recommendation: SELL
Like
Reply
Reputation: 3,089 • May 19 4:43 AM
Sell Dr. Lal PathLabs; target of Rs 895: Prabhudas Lilladher
Prabhudas Lilladher is bearish on Dr. Lal PathLabs has recommended sell rating on the stock with a target price of Rs 895 in its research report dated May 19, 2020.
Moneycontrol
Like
Reply

*Result Highlight*
Glaxosmithkline Pharmaceuticals Ltd. Q4 Cons: Net profit down -6% at Rs. 138.07 cr. Vs Rs. 146.81 cr. (YoY) and Revenue up 3.3% at Rs. 775.8 cr. Vs Rs. 750.81 cr. (YoY)
Board of Directors recommend a Dividend of Rs 40 per equity share of face value of Rs.10 eac...
Read more...
3
Reply
Reputation: 3,089 • May 9 1:43 AM
Opportunity is pharma is huge, advise investors to invest: Motilal Oswal
As lockdown mode could continue and the government's ability to come out with an aggressive bailout package is limited, it's difficult to make out a case for big upside in the short run.
Moneycontrol
Like
Reply
Reputation: -14,779 • May 8 4:38 AM

*DR LAL PATHLAB Rs 16.15 CRS NSE BLOCK FOR ~ 100350 SHARES, AT RS 1609.50*
Like
Reply
Reputation: 3,089 • May 7 5:33 AM
Drop airlines! Here are top 10 stocks based on Warren Buffett's investment methodology
Warren Buffett once again showed investors as to how one can cut losses and preserve cash. The investing phenomenon is dynamic in nature and usually changes over a period of time based on the prevailing trend.
Moneycontrol
Like
Reply